Cite
MLA Citation
E.A. Eksioglu et al.. “286 THE NOVEL FC-ENGINEERED CD33 ANTIBODY BI 836858 IMPROVES HEMATOPOIESIS BY PROTECTING HSC/HPC FROM ROS-MEDIATED DNA DAMAGE IN MDS.” Leukemia research, vol. 39, no. 1, n.d., pp. S142–S143. http://access.bl.uk/ark:/81055/vdc_100059922166.0x000001